Illumina Inc. is a global genomics and life sciences company that develops DNA sequencing and array-based technologies used to analyze genetic variation and biological function. Its products and systems support research, clinical testing, and applied markets across areas such as oncology, inherited and infectious diseases, reproductive health, and molecular diagnostics. Illumina also provides sequencing consumables, instruments, software, and support services that help laboratories generate, interpret, and manage genomic data. The company serves customers including academic institutions, genomic research centers, hospitals, pharmaceutical and biotechnology companies, and clinical laboratories. Headquartered in San Diego, California, and founded in 1998, Illumina plays a central role in making genomic analysis more widely accessible for research and healthcare applications.
Website5200 Illumina Way
San Diego, CA, 92122
United States
Illumina's AI strategy is reshaping the investment case. See how sequencing, biological data, and drug-discovery partnerships could change what drives the company next.
Key Stats for Illumina StockCurrent Price: $273. 90Target Price (Mid): ~$412Street Target: ~$203Potential Total Return: ~50%Annualized IRR: ~10% / yearWhat Happened?Illumina (ILMN) closed at $273.
Index removal puts Illumina in focus Illumina (ILMN) has been removed from the Russell Small Cap Value Index, an index reshuffle that can prompt mechanical selling and raise fresh questions about how the stock is being valued today. The index removal comes at a time when Illumina’s momentum is already strong, with a 1-day share price return of 7.25%, a 30-day share price return of 21.82% and a year-to-date share price return of 103.87%. These feed into a 1-year total shareholder return of...
ILMN's 94.9% YTD rally reflects strong sequencing growth, clinical adoption and a raised 2026 outlook despite China headwinds.
Investors talking about ILMN also mention
| # | Name | Attention |
|---|---|---|
| 1 | Pacific Biosciences of California, Inc. Common StockPACB | 0%0 |
| 2 | 10x Genomics Inc. Class A Common StockTXG | 0%-0.02 |
| 3 | Guardant Health Inc.GH | 0%-0.11 |
| 4 | NVTA - Invitae Corporation | —— |
| 5 | Twist Bioscience CorporationTWST | 0%-0.02 |
| 6 | Beam Therapeutics IncBEAM | 0.02%+0.02 |
| 7 | CRISPR Therapeutics AGCRSP | 0%0 |
| 8 | ARK Genomic Revolution ETFARKG | 0.25%+0.09 |
| 9 | Editas Medicine, Inc.EDIT | 0%+0 |
| 10 | Thermo Fisher Scientific Inc.TMO | 0%0 |
What share of all stock conversation is about ILMN?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% +0 | 0.01% +0 | 0.03% +0.02 | 0.01% 0 |
Of the messages about ILMN that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | 84.96% -8.95 | 64.06% -31.35 | 92.15% +8.13 | ||
| Bearish | — | 15.04% +8.95 | 35.94% +31.35 | 7.85% -8.13 |
Of the messages about ILMN that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | 35.94% | 85.29% | 40.22% | ||
| Technical Analysis | — | 17.19% | 3.5% | 4.23% | ||
| Macro | — | 10.94% | 5.03% | 31.67% | ||
| Earnings | — | 10.94% | 1.01% | 2.19% | ||
| Analysts | — | 10.94% | 4.97% | 19.74% | ||
| Controversies | — | 14.06% | 0.19% | 1.95% |
Of the messages about ILMN, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 0% | 50.13% | 46.5% | 22.43% | ||
| Newcomers | 100% | 49.87% | 53.5% | 77.57% |